• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AOMORI OLYMPUS CO., LTD. DISTAL ATTACHMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AOMORI OLYMPUS CO., LTD. DISTAL ATTACHMENT Back to Search Results
Model Number MH-593
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001)
Event Date 08/23/2022
Event Type  Injury  
Event Description
Olympus reviewed the following literature titled, "modified cap-assisted endoscopic mucosal resection versus endoscopic submucosal dissection for the treatment of rectal neuroendocrine tumors #10 mm: a randomized noninferiority tria".Introduction: although recent guidelines recommend endoscopic resection of rectal neuroendocrine tumors (net) =10 mm, there is no consensus on which endoscopic modality should be performed.We aimed to compare the safety and efficacy of modified cap-assisted endoscopic mucosal resection (memr-c) and endoscopic submucosal dissection (esd) methods for the treatment of rectal net =10 mm.Methods: a randomized noninferiority trial comparing memr-c and esd was conducted.The primary outcome was the histological complete resection rate; the secondary outcomes included en bloc resection rate, operation time, complications, and so on.Subgroup analyses and follow-up were also performed.Results: ninety patients were enrolled, and 79 patients with pathologically confirmed rectal net were finally analyzed, including 38 cases of memr-c and 41 cases of esd.Histological complete resection rate was 97.4% in the memr-c group and 92.7% in the esd group.The noninferiority of memr-c compared with that of esd was confirmed because the absolute difference was 4.7% (2-sided 90% confidence interval, -3.3% to 12.2%; p = 0.616).En bloc resection and successful removal of rectal net were achieved in all patients.Advantages of memr-c over esd included shorter operation time (8.89 ± 4.58 vs 24.8 ± 9.14 minutes, p < 0.05) and lower hospitalization cost ($2,233.76 ± $717.70 vs $2,987.27 ± $871.81, p < 0.05).Postoperative complications were recorded in 4 patients who received memr-c and 2 patients in the esd group (11.5% vs 4.9%, p = 0.509), which were all well managed using endoscopy.Similar findings were observed when subgroup analysis was performed.Type of adverse events/number of patient: bleeding (n = 5).Perofration (n = 1).This literature article requires 2 reports.The related patient identifiers are as follows: (b)(6)(for mh-593).(b)(6)(for kd-655q).This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation and correction to the initial with information inadvertently left out.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Event Description
Additional information received confirms no malfunction or potential adverse event occurred when using olympus device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DISTAL ATTACHMENT
Type of Device
DISTAL ATTACHMENT
Manufacturer (Section D)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori 036-0 357
JA  036-0357
Manufacturer (Section G)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16401635
MDR Text Key309874088
Report Number9614641-2023-00247
Device Sequence Number1
Product Code FDS
UDI-Device Identifier04953170047978
UDI-Public04953170047978
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K984358
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMH-593
Device Lot NumberUNKNOWN(LITERATURE)
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/19/2023
Initial Date FDA Received02/20/2023
Supplement Dates Manufacturer Received06/14/2023
Supplement Dates FDA Received07/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
NON-OLYMPUS DEVICE: T-TYPE ESD KNIFE
Patient Outcome(s) Other; Required Intervention;
-
-